An open-label phase II trial to assess to efficacy of sunitinib as an antieffusion agent in patients with malignant peritoneal and/or pleural effusions

被引：0
|
作者：
Trinh, X.
van Dam, P.
Tjalma, W.
Wojtasik, A.
Lybaert, W.
Rasschaert, M.
Rutten, A.
Prove, A.
Vermeulen, P.
Dirix, L.
机构：
[1] St Augustinus Hosp, Iridium Kankernetwerk, Antwerp, Belgium
[2] Univ Antwerp Hosp, Edegem, Belgium
[3] Iridium Kankernetwerk, AZ Nikolaas, St Niklaas, Belgium
[4] St Vincentius Hosp, Iridium Kankernetwerk, Antwerp, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14647
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
    Faivre, Sandrine
    Raymond, Eric
    Boucher, Eveline
    Douillard, Jean
    Lim, Ho Y.
    Kim, Jun S.
    Zappa, Magaly
    Lanzalone, Silvana
    Lin, Xun
    DePrimo, Samuel
    Harmon, Charles
    Ruiz-Garcia, Ana
    Lechuga, Maria J.
    Cheng, Ann Lii
    LANCET ONCOLOGY, 2009, 10 (08): : 794 - 800
  • [2] An open-label, multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer.
    Moehler, M. H.
    Hartmann, J. T.
    Lordick, F.
    Al-Batran, S.
    Reimer, P.
    Trarbach, T.
    Ebert, M. P.
    Daum, S.
    Weihrauch, M.
    Galle, P. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Phase II open-label study of sunitinib in patients with advanced breast cancer
    Denise A. Yardley
    E. Claire Dees
    Stephen D. Myers
    Sherry Li
    Paul Healey
    Zhixiao Wang
    Marla J. Brickman
    Jolanda Paolini
    Kenneth A. Kern
    Dennis L. Citrin
    Breast Cancer Research and Treatment, 2012, 136 : 759 - 767
  • [4] Phase II open-label study of sunitinib in patients with advanced breast cancer
    Yardley, Denise A.
    Dees, E. Claire
    Myers, Stephen D.
    Li, Sherry
    Healey, Paul
    Wang, Zhixiao
    Brickman, Marla J.
    Paolini, Jolanda
    Kern, Kenneth A.
    Citrin, Dennis L.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) : 759 - 767
  • [5] Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label randomised controlled trial
    Psallidas, Ioannis
    Hassan, Maged
    Yousuf, Ahmed
    Duncan, Tracy
    Khan, Shahul Leyakathali
    Blyth, Kevin G.
    Evison, Matthew
    Corcoran, John P.
    Barnes, Simon
    Reddy, Raja
    Bonta, Peter, I
    Bhatnagar, Rahul
    Kagithala, Gayathri
    Dobson, Melissa
    Knight, Ruth
    Dutton, Susan J.
    Luengo-Fernandez, Ramon
    Hedley, Emma
    Piotrowska, Hania
    Brown, Louise
    Asa'ari, Kamal Abi Musa
    Mercer, Rachel M.
    Asciak, Rachelle
    Bedawi, Eihab O.
    Hallifax, Rob J.
    Slade, Mark
    Benamore, Rachel
    Edey, Anthony
    Miller, Robert F.
    Maskell, Nick A.
    Rahman, Najib M.
    LANCET RESPIRATORY MEDICINE, 2022, 10 (02): : 139 - 148
  • [6] A two-stage, open-label, phase II study of bortezomib plus oxaliplatin in previously treated patients with malignant pleural or peritoneal mesothelioma
    Bates, Gleneara Elizabeth
    Taub, Robert N.
    Borczuk, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial
    Bayman, Neil
    Appel, Wiebke
    Ashcroft, Linda
    Baldwin, David R.
    Bates, Andrew
    Darlison, Liz
    Edwards, John G.
    Ezhil, Veni
    Gilligan, David
    Hatton, Matthew
    Jegannathen, Apurna
    Mansy, Talal
    Peake, Michael D.
    Pemberton, Laura
    Rintoul, Robert C.
    Snee, Michael
    Ryder, W. David
    Taylor, Paul
    Faivre-Finn, Corinne
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (14) : 1200 - +
  • [8] Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
    Kroiss, Matthias
    Quinkler, Marcus
    Johanssen, Sarah
    van Erp, Nielka P.
    Lankheet, Nienke
    Poellinger, Alexander
    Laubner, Katharina
    Strasburger, Christian J.
    Hahner, Stefanie
    Mueller, Hans-Helge
    Allolio, Bruno
    Fassnacht, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3495 - 3503
  • [9] Phase II trial of oxaliplatin and gemcitabine in patients with malignant pleural or peritoneal mesothelioma
    Hare, E.
    Hesdorrfer, M. E.
    Leinwand, J.
    Batista, L.
    Taub, R. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
    Thomas, Anish
    Rajan, Arun
    Berman, Arlene
    Tomita, Yusuke
    Brzezniak, Christina
    Lee, Min-Jung
    Lee, Sunmin
    Ling, Alexander
    Spittler, Aaron J.
    Carter, Corey A.
    Guha, Udayan
    Wang, Yisong
    Szabo, Eva
    Meltzer, Paul
    Steinberg, Seth M.
    Trepel, Jane B.
    Loehrer, Patrick J.
    Giaccone, Giuseppe
    LANCET ONCOLOGY, 2015, 16 (02): : 177 - 186
12345